Analyst desks were busy Saturday. Three firms moved their targets on DRI after the restaurant group's latest results, but they couldn't agree on direction.
Mizuho's Nick Setyan raised his target to $245 from $235, keeping a Buy. Freedom Capital Markets also lifted to $260. BMO Capital went the other way. Andrew Strelzik cut his Hold target to $220 from $225. The split reflects genuine uncertainty over Darden's traffic recovery pace.
CRL drew bullish attention from two Barclays and Mizuho analysts. Barclays' Luke Sergott raised his Buy target to $330 from $300. Mizuho's Ann Hynes lifted her Hold target to $295 from $264. Charles River Labs has a market cap of $14bn. Both firms appear encouraged by contract research demand stabilising.
The cleanest call of the day came from Bernstein. James Hooper initiated CF Industries with a Buy and a $162 target. CF is a nitrogen fertiliser producer with a $17.4bn market cap. Short interest sits at 6.3% of free float — not extreme, but the initiation adds a credible bull case.
COST faced mild headwinds. Mizuho trimmed its Costco target to $1,065 from $1,100. Bernstein nudged theirs down by $1 to $1,143. Both kept Buy ratings. The cuts are modest given the stock's run.
PAYX saw the consensus target drop to $113.93 from $117.29 with no rating change.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
